The Trump administration moved swiftly this month to pour more than $2 billion into nine quantum computing firms. In return the government took minority equity stakes. Commerce Secretary Howard Lutnick hailed the deals. “With today’s CHIPS Research and Development investments in quantum computing, the Trump administration is leading the world into a new era of American innovation,” he said in the official announcement from the National Institute of Standards and Technology.
Yet the funding source has triggered sharp pushback. The money comes from the 2022 CHIPS and Science Act. That legislation targeted microelectronics research and development centered on semiconductor technology. Representative Zoe Lofgren, the ranking Democrat on the House Science, Space, and Technology Committee, called the move illegal.
“This announcement is illegal and troubling on so many levels,” Lofgren stated the day after the May 21 disclosure. She pointed out that the statute specified support for public-private research partnerships focused on semiconductors. Quantum processors overlap only partially with that domain at best. The deals, she argued, bypassed those requirements entirely. Ars Technica first highlighted the dispute in detail.
The largest single commitment, roughly $1 billion, flowed to a new entity called Anderon. IBM contributed another $1 billion in cash, personnel, intellectual property and expertise. The venture will operate as a specialized foundry producing quantum processing units based on superconducting transmon technology. It will fabricate chips for IBM itself and for other companies pursuing similar hardware approaches. The arrangement echoes TSMC’s model but narrows the focus to one qubit modality.
Other recipients each received around $100 million. They include Rigetti Computing, D-Wave Quantum, Infleqtion, Atom Computing, PsiQuantum, Quantinuum and Diraq, which got up to $38 million. GlobalFoundries landed $375 million as one of two designated quantum foundries. The government will hold non-controlling equity in each firm. D-Wave confirmed its entire award takes the form of equity. Similar structures apply to several others. The Wall Street Journal reported these terms along with IBM CEO Arvind Krishna’s optimistic forecast. He compared the moment to AI chips a decade ago and predicted the new business could generate billions in annual sales with high margins by the mid-2030s.
Officials framed the portfolio as a deliberate spread of bets across competing modalities. Neutral atoms, silicon spin, superconducting, photonic and trapped-ion systems all received support. The explicit goal is solving concrete engineering bottlenecks. Reproducibility of devices, optical complexity, error rates and cryogenic scaling top the list. Bill Frauenhofer, who leads the CHIPS R&D office, described the strategy as strengthening U.S. leadership across multiple platforms simultaneously while targeting problems of genuine consequence.
And yet the legal foundation remains contested. The CHIPS Act language does not explicitly authorize equity investments in pure-play quantum startups or the creation of a dedicated foundry outside traditional semiconductor parameters. Lofgren noted that a former IBM executive now serving as under secretary for science at the Department of Energy appeared involved in shaping the agreements. She stopped short of alleging impropriety but insisted Congress never appropriated funds for this exact purpose.
Stopping the transfers will prove difficult. Any lawsuit would require a plaintiff with clear standing. A semiconductor-focused consortium that lost out on the redirected resources might qualify. Court proceedings, however, would likely drag on long after the money has been spent. So the deals proceed. The administration has also signaled work on a new executive order to further bolster the sector.
Recent developments add context. Harvard researchers reported in early May that progress toward fault-tolerant systems has accelerated faster than many forecasts. Useful large-scale machines could arrive by the end of the decade. The Harvard Gazette detailed how three startups spun from that work have already attracted commercial traction and acquisition interest. On the theoretical side, a Simons Foundation team overturned a long-standing claim of quantum supremacy. They showed that classical tensor-network methods can simulate certain hundreds-of-qubits systems once thought intractable. The finding, published May 21 in Science, underscores that benchmarks continue to evolve rapidly.
Export controls have tightened in parallel. A 2024 Bureau of Industry and Security rule placed quantum hardware, software and related technology under strict licensing. Presumption of denial applies to many destinations. These measures reflect the same national-security imperative driving domestic investment. Yet they also highlight how quantum sits at the intersection of research freedom and strategic competition.
Industry voices express measured excitement mixed with realism. One analyst told the Journal that “everybody is excited about quantum because it is the next big thing. A lot of the expectations and hopes have yet to be realized.” The technology remains years from delivering on promises in drug discovery, materials science or code-breaking. Error-corrected logical qubits at scale still lie ahead. But the pace of iteration has quickened. Government capital at this moment could determine which architectures survive the next funding winter.
The equity model itself marks a departure. Previous CHIPS awards emphasized grants or loans without ownership. Lutnick has defended the approach by arguing taxpayers stand to gain if the companies succeed. The administration has struck similar equity deals in rare-earth magnets and other critical materials. Critics, including some at the Cato Institute, see the pattern as an improvised sovereign-wealth fund operating under executive discretion. They warn it skirts congressional oversight and risks repeating past failures where political credit-seeking follows any high-profile flop.
IBM’s decision to spin out its fabrication assets into Anderon carries strategic weight. The company has long benefited from in-house materials science and rapid prototyping. Google opened its own quantum fabrication facility for similar reasons. By sharing the burden with Washington, IBM reduces its capital outlay while retaining priority access. Smaller transmon designers gain a dedicated high-quality foundry instead of competing for limited slots in academic or general-purpose fabs. That alone could accelerate experimentation across the superconducting camp.
Questions linger about long-term demand. Utility-scale quantum computers will likely operate in a handful of cooled data centers and be accessed remotely. The physical chip market may never reach the volume of classical semiconductors. A boom in prototype fabrication could give way to bust once designs stabilize. Anderon’s viability will hinge on whether multiple competing firms continue to pursue transmons or migrate to other modalities that the new foundry cannot serve.
Legal scholars and policy analysts have warned for years that quantum raises novel issues around intellectual property, cryptography migration and regulatory gaps. A February 2026 Global Legal Insights report outlined export restrictions and patent challenges specific to the field. Insurance experts at Hogan Lovells noted in a recent brief that quantum’s threat to current encryption will create new liability exposures for companies slow to adopt post-quantum standards. These broader concerns receive less attention amid the immediate fight over funding authority.
Congress passed the original National Quantum Initiative in 2018. A reauthorization bill advanced through Senate committee in April 2026. It expands definitions to cover quantum applications in space, aeronautics and other domains. Yet it does not resolve the narrower dispute over whether CHIPS Act dollars can pivot so decisively toward one emerging technology. Lawmakers may need to clarify the statute or pass supplemental appropriations. Until then the deals rest on an interpretation that at least one key legislator deems unlawful.
The stakes extend beyond any single company. Quantum leadership carries implications for encryption, simulation of complex molecules and optimization problems that classical machines handle poorly. China has mounted its own aggressive program. The United States has countered with talent recruitment, export controls and now direct equity participation. Success is not guaranteed. Failure to resolve the legal cloud could chill future attempts to back high-risk frontier technologies through existing statutes.
For now the checks have been written. The foundry is launching. Nine teams have fresh resources to attack stubborn error rates and scaling barriers. Whether the bet complies with congressional intent will be debated in hearings, possibly in court, and certainly in the next round of appropriations. The technology marches forward regardless. So does the argument over who gets to decide how public research dollars are spent when the future itself remains uncertain.
WebProNews is an iEntry Publication